The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Today marks National Women and Girls HIV/AIDS Awareness Day, a time to raise awareness about the impact of HIV and AIDS on women and girls.

Kenya has the seventh-largest number of people living with HIV in the world, at around 1.4 million, according to World Health ...

The programme has lived up to its promise. The investment of over US$110 billion since being launched has been transformative ...